IP Library Assignment 041244/0317
Patent Assignment
Reel/Frame 041244/0317

Change of Name

Recorded: 2017-01-04 Pages: 2
Assignor
NEURON SYSTEMS, INC.
Executed: 2012-12-20
Assignee
ALDEXA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Patent: 9,650,342 →
Application: 15/049,890 →
Publication: US 2016/0168098
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 4, 2017
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 040837/0806 →
Change of Name Jan 4, 2017
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 041244/0319 →
Change of Address Jan 4, 2017
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 041251/0216 →
Security Interest Nov 13, 2017
From: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 044106/0800 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →